Article
Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Genes, chromosomes & cancer - 1 Sept 1999
Clifford S C, Walsh S, Hewson K, Green E K, Brinke A, Green P M, Gianelli F, Eng C, Maher E R
Abstract excerpt
Germline mutations in the von Hippel-Lindau (VHL) disease tumor suppressor gene (TSG) convey a high risk of clear-cell renal-cell carcinoma (CC-RCC) and most sporadic CC-RCCs demonstrate somatic inactivation of the VHL TSG. However, the existence of further CC-RCC gatekeeper genes is implied by CC-RCC kindreds not linked to the VHL gene and the absence of somatic VHL inactivation in approximately 30% of sporadic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
